1. Home
  2. CMPX vs ATLO Comparison

CMPX vs ATLO Comparison

Compare CMPX & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPX
  • ATLO
  • Stock Information
  • Founded
  • CMPX 2014
  • ATLO 1903
  • Country
  • CMPX United States
  • ATLO United States
  • Employees
  • CMPX N/A
  • ATLO N/A
  • Industry
  • CMPX Biotechnology: Pharmaceutical Preparations
  • ATLO Major Banks
  • Sector
  • CMPX Health Care
  • ATLO Finance
  • Exchange
  • CMPX Nasdaq
  • ATLO Nasdaq
  • Market Cap
  • CMPX 291.8M
  • ATLO 158.4M
  • IPO Year
  • CMPX N/A
  • ATLO N/A
  • Fundamental
  • Price
  • CMPX $2.65
  • ATLO $18.10
  • Analyst Decision
  • CMPX Strong Buy
  • ATLO
  • Analyst Count
  • CMPX 9
  • ATLO 0
  • Target Price
  • CMPX $12.67
  • ATLO N/A
  • AVG Volume (30 Days)
  • CMPX 797.6K
  • ATLO 17.8K
  • Earning Date
  • CMPX 08-11-2025
  • ATLO 08-08-2025
  • Dividend Yield
  • CMPX N/A
  • ATLO 4.35%
  • EPS Growth
  • CMPX N/A
  • ATLO 14.69
  • EPS
  • CMPX N/A
  • ATLO 1.27
  • Revenue
  • CMPX $850,000.00
  • ATLO $55,041,000.00
  • Revenue This Year
  • CMPX N/A
  • ATLO N/A
  • Revenue Next Year
  • CMPX N/A
  • ATLO N/A
  • P/E Ratio
  • CMPX N/A
  • ATLO $14.54
  • Revenue Growth
  • CMPX N/A
  • ATLO 6.77
  • 52 Week Low
  • CMPX $0.87
  • ATLO $15.69
  • 52 Week High
  • CMPX $4.08
  • ATLO $22.03
  • Technical
  • Relative Strength Index (RSI)
  • CMPX 64.52
  • ATLO 59.86
  • Support Level
  • CMPX $2.62
  • ATLO $18.16
  • Resistance Level
  • CMPX $2.87
  • ATLO $18.68
  • Average True Range (ATR)
  • CMPX 0.16
  • ATLO 0.34
  • MACD
  • CMPX 0.00
  • ATLO 0.08
  • Stochastic Oscillator
  • CMPX 81.03
  • ATLO 83.13

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.

Share on Social Networks: